BR9913627A - Uso de um derivado de antraciclina para o tratamento de um tumor no fìgado - Google Patents

Uso de um derivado de antraciclina para o tratamento de um tumor no fìgado

Info

Publication number
BR9913627A
BR9913627A BR9913627-9A BR9913627A BR9913627A BR 9913627 A BR9913627 A BR 9913627A BR 9913627 A BR9913627 A BR 9913627A BR 9913627 A BR9913627 A BR 9913627A
Authority
BR
Brazil
Prior art keywords
treatment
liver tumor
liver
anthracycline derivative
tumor
Prior art date
Application number
BR9913627-9A
Other languages
English (en)
Inventor
Maria Pacciarini
Olga Valota
David Kerr
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of BR9913627A publication Critical patent/BR9913627A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

USO DE UM DERIVADO DE ANTRACICLINA PARA O TRATAMENTO DE UM TUMOR NO FìGADO A presente invenção relata o uso da metoximorfolino doxorubicina para o tratamento de um câncer no fígado; em particular, refere-se à administração intra-hepática da metoximorfolino doxorubicina para uso na terapia do tumor de fígado opcionalmente em associação com um agente que permanece seletivamente em tumor de fígado após sua injeção através da artéria hepática.
BR9913627-9A 1998-09-14 1999-08-27 Uso de um derivado de antraciclina para o tratamento de um tumor no fìgado BR9913627A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9820012.4A GB9820012D0 (en) 1998-09-14 1998-09-14 Use of an anthracycline derivative for the treatment of a liver tumor
PCT/EP1999/006298 WO2000015203A2 (en) 1998-09-14 1999-08-27 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor

Publications (1)

Publication Number Publication Date
BR9913627A true BR9913627A (pt) 2001-05-22

Family

ID=10838847

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913627-9A BR9913627A (pt) 1998-09-14 1999-08-27 Uso de um derivado de antraciclina para o tratamento de um tumor no fìgado

Country Status (26)

Country Link
EP (1) EP1112066B1 (pt)
JP (2) JP5529360B2 (pt)
KR (1) KR100685155B1 (pt)
CN (1) CN1168452C (pt)
AT (1) ATE245029T1 (pt)
AU (1) AU773451B2 (pt)
BR (1) BR9913627A (pt)
CA (1) CA2343120C (pt)
CZ (1) CZ295901B6 (pt)
DE (1) DE69909636T2 (pt)
DK (1) DK1112066T3 (pt)
EA (1) EA004570B1 (pt)
ES (1) ES2203175T3 (pt)
GB (1) GB9820012D0 (pt)
HK (1) HK1050853A1 (pt)
HU (1) HU229186B1 (pt)
ID (1) ID28035A (pt)
IL (2) IL141645A0 (pt)
MY (1) MY124247A (pt)
NO (1) NO329746B1 (pt)
NZ (1) NZ510445A (pt)
PL (1) PL198025B1 (pt)
PT (1) PT1112066E (pt)
TW (1) TWI222868B (pt)
UA (1) UA69423C2 (pt)
WO (1) WO2000015203A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
WO2004038404A2 (en) * 2002-10-28 2004-05-06 Pharmacia Italia Spa Method for optimizing therapeutic efficacy of nemorubicin
US20060264388A1 (en) * 2003-02-26 2006-11-23 Olga Valota Method for treating liver cancer by intrahepatic administration of nemorubicin
US8940334B2 (en) 2007-05-11 2015-01-27 Nerviano Medical Sciences S.R.L. Pharmaceutical composition of an anthracycline
JP2016124818A (ja) * 2014-12-26 2016-07-11 日本化薬株式会社 転移性肝癌治療薬及び転移性肝癌の治療方法
PL244818B1 (pl) * 2021-11-03 2024-03-11 Urteste Spolka Z Ograniczona Odpowiedzialnoscia Związek-marker diagnostyczny raka wątroby, sposób wykrywania aktywności enzymatycznej, sposób diagnozowania raka wątroby, zestaw zawierający taki związek oraz związek do zastosowania medycznego

Also Published As

Publication number Publication date
EA200100353A1 (ru) 2001-10-22
GB9820012D0 (en) 1998-11-04
MY124247A (en) 2006-06-30
EP1112066A2 (en) 2001-07-04
WO2000015203A3 (en) 2000-07-20
TWI222868B (en) 2004-11-01
NO329746B1 (no) 2010-12-13
DE69909636T2 (de) 2004-06-09
NO20011116D0 (no) 2001-03-05
HUP0103557A2 (hu) 2002-01-28
KR100685155B1 (ko) 2007-02-22
NZ510445A (en) 2003-01-31
PL198025B1 (pl) 2008-05-30
KR20010075074A (ko) 2001-08-09
DE69909636D1 (de) 2003-08-21
IL141645A0 (en) 2002-03-10
CN1168452C (zh) 2004-09-29
NO20011116L (no) 2001-05-14
AU773451B2 (en) 2004-05-27
PT1112066E (pt) 2003-11-28
CA2343120C (en) 2009-11-24
ATE245029T1 (de) 2003-08-15
UA69423C2 (uk) 2004-09-15
CZ295901B6 (cs) 2005-11-16
IL141645A (en) 2007-05-15
CA2343120A1 (en) 2000-03-23
JP2002524496A (ja) 2002-08-06
ES2203175T3 (es) 2004-04-01
JP2014088398A (ja) 2014-05-15
EP1112066B1 (en) 2003-07-16
WO2000015203A2 (en) 2000-03-23
DK1112066T3 (da) 2003-11-03
EA004570B1 (ru) 2004-06-24
HK1050853A1 (en) 2003-07-11
ID28035A (id) 2001-05-03
JP5529360B2 (ja) 2014-06-25
CZ2001895A3 (cs) 2001-08-15
HUP0103557A3 (en) 2002-12-28
PL348749A1 (en) 2002-06-03
CN1383382A (zh) 2002-12-04
HU229186B1 (en) 2013-09-30
AU5742199A (en) 2000-04-03

Similar Documents

Publication Publication Date Title
BRPI0410503B8 (pt) composição tópica e uso da composição
PT1035834E (pt) Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
ATE320793T1 (de) Verabreichung von einer chemoschützenden verbindung,welche eine thiolgruppe enthält
BRPI0507684B8 (pt) agentes de contraste para imagem de perfusão miocárdica
BR0014491A (pt) Bactérias atenuadas marcadas para tumor, composição farmacêutica, uso de bactérias atenuadas, e, proteina de fusão
BR9709942A (pt) Uso de um composto composição farmacêutica embalagem e processo de tratamento de organismo de animal humano ou não humano para combater ou prevenircondições associadas com a presença de radicais livres no organismo
UY26456A1 (es) Compuestos que fijan la estructura g-cuadruplex de los telomeros, triazinas de aplicación de dichos compuestos, la utilización de dichos compuestos como productos farmacéuticos y las asociaciones terapéuticas que los incluyen.
AR023616A1 (es) Preparaciones combinadas que comprenden derivados de antraciclina
BR9908391A (pt) Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina
AR021750A1 (es) Aparato para el tratamiento topico localizado de una enfermedad
BR8905657A (pt) Processo para preparar um quelante bifuncional,processo para preparar um complexo de um composto,processo para preparar um conjugado e processo para preparar uma formulacao farmaceutica
BR9913627A (pt) Uso de um derivado de antraciclina para o tratamento de um tumor no fìgado
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
BR9814419A (pt) "combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas"
BR0113148A (pt) Composições de 2-piridinamina e métodos relacionados
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
BRPI0408518A (pt) terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2
AR018475A1 (es) Composicion de resorcinol
BR0014192A (pt) Conjugados de corantes e anticorpos contra estruturas-alvo da angiogênese, para representação intra-operativa da margem de tumores
BRPI0408494A (pt) terapia combinada contra tumores compreendendo nemorubicina com terapia de radiação
AR027677A1 (es) Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer
BR0009473A (pt) Tratamento de extravasamento acidental deantraciclinas
BR0306809A (pt) Sistema terapêutico para o tratamento de tumores, método de tratamento de um tumor, e, uso de uma combinação de um anticorpo radiomarcado e um agente quimioterapêutico
CO5170459A1 (es) Terapia transdermica con agonistas-antagonistas de estrogenos len-ol, administrados mediante medios transdermicos

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO ESTABELECIDO PELOS ARTIGOS 8O E 13 DA LPI ( LEI 9729/96)

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: MERVIANO MEDICAL SCIENCES S.R.L. (IT)

Free format text: TRANSFERIDO DE: PHARMACIA AND UPJOHN S.P.A.